marcus evans europe conferences

2nd Annual Portfolio Management Strategies for Generics and Biosimilars

Foster Performance and Growth in Competitive Markets, Benefit from New Development Opportunities

25-27 September 2017
Amsterdam, Netherlands


Why You Should Attend

2nd Annual Portfolio Management Strategies for Generics and Biosimilars

Do you want to learn more on generics and biosimilars strategies, looking at how companies select their product, align their decision processes with the strategy and find innovative ways of performing within a highly competitive market?

Come and join this marcus evans conference, where the main generics and biosimilars players will discuss the challenges and the promises of affordable drugs development: from the selection and assessment to the launch cycle; looking at the regulatory and patent specificities as well as the ongoing alignment to policies, insurance and healthcare decisions. With price erosion, lower margins, payer reimbursement pressure, and demanding product launch on local market, the optimization of portfolio and product strategy is becoming critical for most of the generic players. Companies are pushed to redefine their internal strategy and organization to be able to perform in different markets and adapt with agility to rapid changes and new opportunities.


Key Topics

  • Gain practical methodology to decision making in generic portfolio
  • Improve internal capabilities to deal with multiple products
  • Ensure alignment between country and global portfolio levels
  • Understand key market drivers and refine price strategy
  • Integrate innovation, added-value and diversification in products
  • Previous Attendees Include

    ABBOTT LABORATORIES, ABBVIE, ASTELLAS, ACTELION, ASTRAZENECA, ALMIRALL, AMGEN, ASTELLAS, BAXALTA, BAXTER, BAYER PHARMA AG, BAYERHEALTHCARE, BIOGEN IDEC, BRISTOL-MYERS SQUIBB, BOEHRINGER INGELHEIM, CELGENE EUROPE LIMITED, CHIESI FARMACEUTICI SPA, DAIICHI-SANKYO, DEBIOPHARM, ELI LILLY, EVOTEC, F.HOFFMANN-LA ROCHE, FERRING INTERNATIONAL, FRESENIUS KABI DEUTSCHLAND GMBH,GENENTECH, GLAXOSMITHKLINE, GRUNENTHAL GMBH, IPSEN, JANSSEN PHARMACEUTICAL, JOHNSON & JOHNSON, MEDIMMUNE, MEDINCELL, MERCK SHARP& DOHME, MERCK PHARMA, MITSUBISHI TANABE PHARMACEUTICALS, NORGINE, NOVARTIS PHARMA, NOVO NORDISK, ORION CORPORATION, PAREXEL, PFIZER, PIERRE FABRE LABORATORIES, SANOFI-AVENTIS, SANOFI BIOPHARMACEUTICALS, SHIRE INTERNATIONAL, STALLERGENES, SERVIER, SWEDISH ORPHAN BIOVITRUM, TAKEDA, TEVA PHARMACEUTICALS, UCB ETC.


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.




    Event Partners


    Practical Insights From

    Erez Hybloom
    Head Of Portfolio & Launch Management Europe
    Teva Pharmaceuticals

    Kuntal Chatterjee
    Global Business Development Manager
    Apotex

    Klemen Spaninger
    Global Head of Project Management and Member of the Management Team
    Polpharma Biologic

    Kirsi Norvasuo-Huber
    Head Portfolio Development & Strategic Markets Customers First Lead
    Sandoz Germany

    Árni Hrannar Haraldsson
    SVP Business Development & Supply Chain Management
    Xantis Pharma AG

    Greg Perry
    Executive Director
    The Medicines Patent Pool

    Sameer Agarwal
    Senior Vice President-Portfolio & Strategic Marketing, Mature & Emerging Markets
    Fresenius Kabi

    Peter Wittner
    Senior Consultant
    Interpharm Consultancy

    Click Here For Full Agenda

    Voice of Our Customers
    • “The conference is well organised and speakers are all high quality!” - Programme Coordinator, J&J
    • “High quality speakers, enjoyed the networking” - VP, Debiopharm
    • “I appreciated the conference a lot, having the possibility to compare project management actions of my company with the other companies” - Project Manager R&D, Chiesi
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Yiota Andreou


    marcus evans (Europe) Ltd
    PO Box 24797
    Cyprus

    Telephone:
    +357 22 849 404
    Fax: +357 22 849 310
    Email: YiotaA@marcusevanscy.com